These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 17409326)

  • 41. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Dec; 45(12):1281-328. PubMed ID: 18080231
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
    Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
    J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C in the patient with human immunodeficiency virus infection.
    Spengler U; Rockstroh JK
    J Hepatol; 1998 Dec; 29(6):1023-30. PubMed ID: 9875654
    [No Abstract]   [Full Text] [Related]  

  • 44. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of hepatitis C in HIV-coinfected patients at the CROI.
    Barreiro P
    AIDS Rev; 2004; 6(1):63. PubMed ID: 15168743
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 47. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
    [No Abstract]   [Full Text] [Related]  

  • 48. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
    Jablonowski H
    Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis drug gets approval for coinfection treatment.
    AIDS Patient Care STDS; 2005 May; 19(5):351. PubMed ID: 15916498
    [No Abstract]   [Full Text] [Related]  

  • 50. EASL Clinical Practice Guidelines: management of chronic hepatitis B.
    European Association For The Study Of The Liver
    J Hepatol; 2009 Feb; 50(2):227-42. PubMed ID: 19054588
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
    Neumann AU
    Hepatology; 2005 Aug; 42(2):249-54. PubMed ID: 16025494
    [No Abstract]   [Full Text] [Related]  

  • 52. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting treatment outcomes for HBV patients.
    AIDS Patient Care STDS; 2009 Mar; 23(3):223. PubMed ID: 19480059
    [No Abstract]   [Full Text] [Related]  

  • 59. Treating hepatitis C in patients with cirrhosis: the effort is worth it.
    Forns X; Bruix J
    J Hepatol; 2010 May; 52(5):624-6. PubMed ID: 20334945
    [No Abstract]   [Full Text] [Related]  

  • 60. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.